The primary objective is to assess the change of systolic blood pressure from baseline after a 6-month follow up for hypertensive patients initiating Viacoram® plus an educational program (NGAYDAUTIEN) in comparison to hypertensive patients initiating other antihypertensive drugs (except single pill combination).

Inclusion Criteria:

1. Aged of at least 18 years (without upper limit of age)

2. Diagnosis of grade 1 or grade 2 hypertension

3. Naïve of treatment:

   • newly diagnosed hypertension and without treatment with antihypertensive effect for at least 3 months
   • previously diagnosed but without treatment with antihypertensive effect for at least 3 months

4. Patients follow-up within the scope of the current medical practice and in the same health centre during the 6-month period

Exclusion Criteria:

1. Previously attended to the Ngay Dau Tien educational program for HBP management
2. Plan to be hospitalized for other medical conditions during the next 6 months
3. Plan to move/relocate during 6-month follow-up
4. Have a severe disease (i.e. cirrhosis, end-stage renal disease …)
5. Are unlikely to cooperate in the study
6. Arm 1: patient having contra-indication to take Viacoram® according to SmPC
7. Arm 2: patient showing interest in attending NDT educational program.

Male and female who have a diagnosis of grade 1 or 2 hypertension and who initiate a new antihypertensive treatment